Deal Announcements

AxoGen Adds $3 Million Venture Capital Debt

Thursday, June 16, 2011 5:37:00 AM PDT | VentureDeal Staff

   Alachua, Florida  --  Medical device company AxoGen has secured $3 million in new venture capital debt financing, according to an regulatory filing.

AxoGen is commercializing peripheral nerve grafting and nerve regeneration technologies licensed from the University of Florida and the University of Texas, as well as other sources.

Investors in the financing were not disclosed. The company is still seeking an additional $2.5 million in financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1